Skip to main content
. Author manuscript; available in PMC: 2012 Aug 27.
Published in final edited form as: Ann Rheum Dis. 2012 Jan 20;71(7):1157–1162. doi: 10.1136/annrheumdis-2011-200493

Table 5.

Disease specific characteristics of rheumatoid arthritis patients with high versus low disease activity/clinical remission defined by the DAS28

Group DAS28 Disease
duration		 TNFI
(% yes)		 MTX
(% yes)		 Other biologic
(% yes)		 Other non-biologic
DMD (% yes)		 Prednsione
(% yes)
DAS28>5.1 (n=18) 6.4±0.8* 16±11 39 61 17 28 44
DAS28<2.6 (n=7) 2.1±0.4   8±7 29 71 14 29   0
*

p Value<0.05 compared to DAS28<2.6 group.

DAS28, disease activity score using 28 joint count; DMD, disease modifying drug; MTX, methotrexate; TNFI, tumour necrosis factor α inhibitor.